Quantcast
Last updated on April 16, 2014 at 8:06 EDT

Latest Cancer Research Stories

2013-08-20 08:31:08

STOCKHOLM, August 20, 2013 /PRNewswire/ -- Oncopeptides AB, a company working to enhance oncology therapies, today announced that the first patient has been dosed as part of a Phase II study in multiple myeloma patients with its drug candidate melflufen (previously called J1). (Logo: http://photos.prnewswire.com/prnh/20130521/613959 ) The trial is an open-label Phase II study designed to determine the level of efficacy of melflufen in combination with...

2013-08-19 13:11:48

A gene that helps control the aging process by acting as a cell's internal clock has been linked to cancer by a major new study. Scientists at The Institute of Cancer Research, London, found a genetic variant that influences the aging process among four new variants they linked to myeloma – one of the most common types of blood cancer. The study more than doubles the number of genetic variants linked to myeloma, bringing the total number to seven, and sheds important new light on the...

2013-08-17 23:03:31

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses the possibility of brain cancer treatment becoming personally-tailored to each patient’s individual case. New York, NY (PRWEB) August 17, 2013 On August 17, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, discusses the possibility of brain cancer treatment becoming personally-tailored to patients’ individual needs and cases....

2013-08-14 16:25:28

'Project Violet' aims to speed drug discovery using scaffolds from nature and crowdfunding SEATTLE, Aug. 14, 2013 /PRNewswire/ -- A spirited, red-headed girl named Violet who died at age 11 from an inoperable brainstem tumor is the inspiration behind "Project Violet," a "citizen science" drug-discovery project being launched by Fred Hutchinson Cancer Research Center. The project is using crowdfunding to enlist the help of the community to develop a fundamentally new class of anti-cancer...

2013-08-13 23:26:53

The “Let’s Kick This” Charity Soccer Tournament, on August 24, 2013, will benefit Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy. New York, NY (PRWEB) August 13, 2013 On August 13, “Let’s Kick This” invites the Tri-State community to sign up and participate in its inaugural “Let’s Kick This Charity Soccer Tournament” on Saturday, August 24, 2013 at Chelsea Waterside Park (W 23rd Street & 11th Avenue) for the benefit of...

2013-08-12 23:17:50

Celebrated cyclist to serve as celebrity emcee and participant of inaugural charity ride. Goodyear, AZ (PRWEB) August 12, 2013 Trails 4 Trials, the first organized charity ride in Arizona’s Southwest Valley, will welcome celebrated cyclist and coach Robbie Ventura as its celebrity guest. The two-time El Tour de Tucson winner and former professional cyclist will serve as the Sept. 28 event’s emcee and race participant while also providing exclusive VIP perks for sponsors and top...

2013-08-12 23:17:43

The Barn Bash for Brain Cancer Research is celebrating Megan Patton’s 16 year battle with brain cancer. Proceeds benefit the patient advocacy organization The Chris Elliott Fund. West Linn, OR (PRWEB) August 12, 2013 The inaugural Barn Bash for Brain Cancer Research will take place at Long Road Farm in West Linn Oregon. Tickets cost $50 and the 21 and over event will feature endless buffet by Joe’s Burgers, music, dancing, and a no host bar. The event will celebrate the life of brain...

2013-08-08 23:23:31

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, announces a $30,000 grant being awarded to Camp Jinka, a summer program for children and teens whose lives have been impacted by brain tumors. New York, NY (PRWEB) August 08, 2013 On August 8, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, announces their donation of a $30,000 grant to Camp Jinka, a summer program for kids and teens whose...

2013-08-08 08:31:02

LOS ANGELES, Aug. 8, 2013 /PRNewswire/ -- Kite Pharma Inc. (Kite), a clinical stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, today announced the appointment of three leading experts in the areas of immunotherapy, chimeric antigen receptor (CAR) technology, and gene therapy to its Scientific Advisory Board (SAB). (Logo: http://photos.prnewswire.com/prnh/20130513/MM13332LOGO) "Kite is fortunate to attract these world-leading...

2013-08-07 23:20:23

New study reveals molecular clues that may help physicians therapeutically target a highly aggressive form of breast cancer. (PRWEB) August 07, 2013 A study led by investigators from Thomas Jefferson University’s Kimmel Cancer Center has discovered molecular clues that may help physicians therapeutically target inflammatory breast cancer (IBC), a highly aggressive form of breast cancer. Their study, reported in the June 21 online issue of Breast Cancer Research and Treatment, identified...